Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:717
doi: 10.1161/CIRCULATIONAHA.109.192598
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Related Collections
Right arrowRelated Articles

(Circulation. 2009;120:717.)
© 2009 American Heart Association, Inc.

Clinical Summaries


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Propranolol Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia Syndrome: Less Is More
 
Postural tachycardia syndrome (POTS) is a disorder of chronic orthostatic intolerance that disproportionately affects women of childbearing age. It is characterized by a constellation of symptoms that occur during standing but resolve with sitting or lying down. A most striking feature of this disorder is the excessive increase in heart rate that occurs on standing in the absence of hypotension. Given the striking tachycardia, β-adrenergic blockers would seem like ideal treatments, but prior anecdotal and experimental experience has been disappointing. We report the first placebo-controlled trial of propranolol in POTS. A low dose of propranolol (20 mg) immediately decreased heart rate and orthostatic tachycardia and improved the orthostatic symptoms in patients with POTS. A higher dose of propranolol (80 mg) elicited more complete β-blockade with a further lowering of heart rate but did not further improve symptoms and may have made some symptoms worse. These data suggest that although low doses of propranolol are of benefit in POTS, higher doses might be counterproductive. These data also offer a potential explanation for the conflicting prior results of β-blockers in POTS. See p 725.


*    Air Temperature and the Occurrence of Myocardial Infarction in Augsburg, Germany
 
Acute myocardial infarctions (MIs) often have an unexplained origin in subjects with underlying medically recognized or unrecognized vulnerability. Several factors have been identified as being associated with the onset of acute MI, including heavy exercise or physical exertion, diet, coffee and alcohol consumption, sexual activity, cocaine or marijuana abuse, emotional stress, and air pollution. Extreme ambient air temperature levels and temperature changes have been hypothesized to be . . . [Full Text of this Article]


Related Articles:

Air Temperature and the Occurrence of Myocardial Infarction in Augsburg, Germany
Kathrin Wolf, Alexandra Schneider, Susanne Breitner, Stephanie von Klot, Christa Meisinger, Josef Cyrys, Heiko Hymer, H. -Erich Wichmann, Annette Peters for the Cooperative Health Research in the Region of Augsburg (KORA) Study Group
Circulation 2009 120: 735-742. [Abstract] [Full Text]

Platelet Dense-Granule Secretion Plays a Critical Role in Thrombosis and Subsequent Vascular Remodeling in Atherosclerotic Mice
Sarah M. King, Rachel A. McNamee, Aiilyan K. Houng, Rakesh Patel, Michael Brands, and Guy L. Reed
Circulation 2009 120: 785-791. [Abstract] [Full Text]

Propranolol Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia Syndrome: Less Is More
Satish R. Raj, Bonnie K. Black, Italo Biaggioni, Sachin Y. Paranjape, Maricelle Ramirez, William D. Dupont, and David Robertson
Circulation 2009 120: 725-734. [Abstract] [Full Text]

Hypercoagulability Inhibits Monocyte Transendothelial Migration Through Protease-Activated Receptor-1-, Phospholipase-Cβ-, Phosphoinositide 3-Kinase-, and Nitric Oxide-Dependent Signaling in Monocytes and Promotes Plaque Stability
Stefanie Seehaus, Khurrum Shahzad, Muhammed Kashif, Ilya A. Vinnikov, Martin Schiller, Hongjie Wang, Thati Madhusudhan, Volker Eckstein, Angelika Bierhaus, Florian Bea, Erwin Blessing, Hartmut Weiler, David Frommhold, Peter P. Nawroth, and Berend Isermann
Circulation 2009 120: 774-784. [Abstract] [Full Text]

Protein Tyrosine Phosphatase 1B, a Major Regulator of Leptin-Mediated Control of Cardiovascular Function
Eric J. Belin de Chantemèle, Kenjiro Muta, James Mintz, Michel L. Tremblay, Mario B. Marrero, David J. Fulton, and David W. Stepp
Circulation 2009 120: 753-763. [Abstract] [Full Text]

T-Type Ca2+ Channel Blockade Prevents Sudden Death in Mice With Heart Failure
Hideyuki Kinoshita, Koichiro Kuwahara, Makoto Takano, Yuji Arai, Yoshihiro Kuwabara, Shinji Yasuno, Yasuaki Nakagawa, Michio Nakanishi, Masaki Harada, Masataka Fujiwara, Masao Murakami, Kenji Ueshima, and Kazuwa Nakao
Circulation 2009 120: 743-752. [Abstract] [Full Text]

Upregulation of Matrix Metalloproteinase-2 in the Arterial Vasculature Contributes to Stiffening and Vasomotor Dysfunction in Patients With Chronic Kidney Disease
Ada W.Y. Chung, H.H. Clarice Yang, Jong Moo Kim, Mhairi K. Sigrist, Elliott Chum, William A. Gourlay, and Adeera Levin
Circulation 2009 120: 792-801. [Abstract] [Full Text]

Increased Expression of Integrin-Linked Kinase Attenuates Left Ventricular Remodeling and Improves Cardiac Function After Myocardial Infarction
Liang Ding, Li Dong, Xin Chen, Lujie Zhang, Xiaoyu Xu, Albert Ferro, and Biao Xu
Circulation 2009 120: 764-773. [Abstract] [Full Text]